Global Retirement Partners LLC Raises Stake in The Beauty Health Company (NASDAQ:SKIN)

Global Retirement Partners LLC lifted its position in shares of The Beauty Health Company (NASDAQ:SKINFree Report) by 359.5% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 119,023 shares of the company’s stock after purchasing an additional 93,123 shares during the quarter. Global Retirement Partners LLC owned about 0.09% of Beauty Health worth $370,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds have also recently bought and sold shares of SKIN. Raymond James Financial Services Advisors Inc. purchased a new stake in shares of Beauty Health during the fourth quarter valued at approximately $31,000. Raymond James & Associates purchased a new stake in shares of Beauty Health during the fourth quarter valued at approximately $31,000. Tower Research Capital LLC TRC increased its stake in shares of Beauty Health by 172.2% in the second quarter. Tower Research Capital LLC TRC now owns 6,666 shares of the company’s stock worth $56,000 after buying an additional 4,217 shares during the last quarter. State of Wyoming increased its stake in shares of Beauty Health by 46.4% in the fourth quarter. State of Wyoming now owns 6,791 shares of the company’s stock worth $62,000 after buying an additional 2,152 shares during the last quarter. Finally, AQR Capital Management LLC bought a new stake in shares of Beauty Health in the third quarter worth $72,000. Hedge funds and other institutional investors own 93.26% of the company’s stock.

Analyst Ratings Changes

A number of brokerages recently issued reports on SKIN. TD Cowen lifted their price target on shares of Beauty Health from $2.50 to $4.00 and gave the stock a “market perform” rating in a research note on Wednesday, March 13th. Canaccord Genuity Group boosted their price target on shares of Beauty Health from $3.00 to $4.00 and gave the company a “hold” rating in a report on Thursday, March 14th. Piper Sandler reissued an “underweight” rating and set a $3.00 price target (up previously from $2.00) on shares of Beauty Health in a report on Wednesday, March 13th. DA Davidson reaffirmed a “buy” rating and issued a $5.00 price objective on shares of Beauty Health in a report on Friday, March 15th. Finally, Stifel Nicolaus reaffirmed a “hold” rating and issued a $4.00 price objective (up previously from $3.00) on shares of Beauty Health in a report on Wednesday, March 13th. Three investment analysts have rated the stock with a sell rating, seven have given a hold rating and two have issued a buy rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Hold” and a consensus price target of $6.50.

View Our Latest Analysis on SKIN

Beauty Health Trading Down 5.6 %

Shares of NASDAQ SKIN opened at $4.04 on Wednesday. The business has a 50 day simple moving average of $3.46 and a 200 day simple moving average of $3.67. The company has a debt-to-equity ratio of 12.43, a quick ratio of 5.28 and a current ratio of 6.07. The stock has a market cap of $498.66 million, a price-to-earnings ratio of -5.25 and a beta of 1.01. The Beauty Health Company has a 52 week low of $1.35 and a 52 week high of $13.90.

Beauty Health (NASDAQ:SKINGet Free Report) last posted its quarterly earnings results on Tuesday, March 12th. The company reported ($0.07) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.11) by $0.04. Beauty Health had a negative return on equity of 18.85% and a negative net margin of 25.65%. The business had revenue of $96.80 million for the quarter, compared to analysts’ expectations of $87.22 million. During the same quarter last year, the business earned $0.03 earnings per share. The firm’s quarterly revenue was down 1.3% compared to the same quarter last year. On average, research analysts predict that The Beauty Health Company will post -0.12 earnings per share for the current fiscal year.

Beauty Health Company Profile

(Free Report)

The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a Delivery System designs to connects providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive, a treatment for scalp health.

Recommended Stories

Want to see what other hedge funds are holding SKIN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Beauty Health Company (NASDAQ:SKINFree Report).

Institutional Ownership by Quarter for Beauty Health (NASDAQ:SKIN)

Receive News & Ratings for Beauty Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Beauty Health and related companies with MarketBeat.com's FREE daily email newsletter.